News
Prothena Announces Review On Birtamimab Mechanism Of Action And Pharmacological Characteristics Published In Leukemia & Lymphoma
15 Apr 24
Biotech, News, General
Cantor Fitzgerald Reiterates Overweight on Prothena Corp
10 Apr 24
News, Reiteration, Analyst Ratings
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
13 Mar 24
Analyst Ratings
HC Wainwright & Co. Maintains Buy on Prothena Corp, Maintains $90 Price Target
13 Mar 24
News, Price Target, Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
29 Feb 24
Options
JMP Securities Maintains Market Outperform on Prothena Corp, Raises Price Target to $85
16 Feb 24
News, Price Target, Analyst Ratings
Decoding 6 Analyst Evaluations For Prothena Corp
16 Feb 24
Analyst Ratings
RBC Capital Maintains Sector Perform on Prothena Corp, Lowers Price Target to $35
16 Feb 24
News, Price Target, Analyst Ratings
Earnings Scheduled For February 15, 2024
15 Feb 24
Earnings
Earnings Outlook For Prothena Corp
14 Feb 24
Earnings
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
30 Jan 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
B of A Securities Downgrades Prothena Corp to Neutral, Lowers Price Target to $38
30 Jan 24
News, Downgrades, Price Target, Analyst Ratings
Navigating 5 Analyst Ratings For Prothena Corp
25 Jan 24
Analyst Ratings
RBC Capital Maintains Sector Perform on Prothena Corp, Lowers Price Target to $36
25 Jan 24
News, Price Target, Analyst Ratings
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today
22 Jan 24
News, Trading Ideas
Press releases
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
15 Apr 24
Press Releases
Prothena to Participate in Upcoming Healthcare Conferences
5 Mar 24
Press Releases
Prothena Appoints David Ford to Newly Created Chief People Officer Position
4 Mar 24
Press Releases